Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.3990
+0.0009 (0.23%)
Aug 15, 2025, 10:06 AM - Market open

Athira Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-59.85-96.94-117.67-95.64-54.85-19.96
Upgrade
Depreciation & Amortization
0.970.970.970.850.480
Upgrade
Loss (Gain) From Sale of Assets
-0.01----
Upgrade
Loss (Gain) From Sale of Investments
-0.28-0.52-1.41-0.420.490.25
Upgrade
Stock-Based Compensation
8.411.0510.6210.614.620.63
Upgrade
Other Operating Activities
0.260.240.210.20.161.4
Upgrade
Change in Accounts Receivable
--1.231.11-1.04-1.3
Upgrade
Change in Accounts Payable
-13.97-5.757.372.15.152.6
Upgrade
Change in Unearned Revenue
------1.5
Upgrade
Change in Other Net Operating Assets
-6.23-6.23-2.078.731.89-6.25
Upgrade
Operating Cash Flow
-70.7-97.17-100.75-72.47-43.1-24.11
Upgrade
Capital Expenditures
--0.03-0.3-1.14-1.57-2.32
Upgrade
Investment in Securities
8.3254.8695.3958.81-2.51-207.78
Upgrade
Other Investing Activities
-----0.04
Upgrade
Investing Cash Flow
8.3254.8395.0957.66-4.08-210.07
Upgrade
Long-Term Debt Issued
-----1.66
Upgrade
Net Debt Issued (Repaid)
-----1.66
Upgrade
Issuance of Common Stock
0.070.190.490.6597.09209.16
Upgrade
Financing Cash Flow
0.070.190.490.6597.09292.75
Upgrade
Net Cash Flow
-62.31-42.15-5.17-14.1549.9158.57
Upgrade
Free Cash Flow
-70.7-97.2-101.06-73.61-44.67-26.43
Upgrade
Free Cash Flow Per Share
-1.82-2.53-2.66-1.95-1.21-2.21
Upgrade
Levered Free Cash Flow
-38.24-60.51-60.9-36.5-31.15-18.95
Upgrade
Unlevered Free Cash Flow
-38.24-60.51-60.9-36.5-31.15-18.72
Upgrade
Change in Working Capital
-20.2-11.986.5311.946.01-6.45
Upgrade
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q